New scalp injection could regrow hair in balding men
NCT ID NCT07327359
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental drug called OLX72021 in 158 men with mild to moderate male pattern baldness. The drug is injected into the scalp at different doses to see if it is safe and can increase hair count compared to a placebo. The trial is currently recruiting participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OLX72021 (an experimental drug injected into the scalp)
What this could lead to
If it works, this could lead to a new treatment option for male pattern baldness that helps regrow hair.
What could go wrong
This is an early-phase trial (Phase 1b/2a) with a small number of participants. The drug may not work better than placebo, and side effects from the injections are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emeritus Research Camberwell
RECRUITINGCamberwell, Victoria, 3124, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••